Yuval Horn was announced as the incoming Co-Chair of the International Bar Association Technology Law Committee
October 19, 2015
Yuval Horn to moderate a panel relating to Regulation of Genetic Testing at the IBA Annual Conference in Vienna in October, 2015
September 2, 2015
Horn & Co. represented cCam Biotherapeutics Ltd. and its shareholders in the acquisition by Merck Sharp & Dohme for $605 million.
July 28, 2015
Taboola.com increases its $117 million private financing round, and closes follow-on investments with Baidu Inc. and DailyMail.com.
June 21, 2015
Horn & Co. listed by iam Magazine (Intellectual Asset Management) as one of the top 6 recommended Israeli firms in the field of Licensing.
June 18, 2015
Adv. Yuval Horn participated in the 3rd Annual IBA World Life Sciences Conference
June 1, 2015
Biolight Israeli Life Sciences Investments Ltd (TASE: BOLT) executes memorandum for strategic cooperation in China and closes $6.2 million investment with investors based in Hong Kong.
May 12, 2015
Angioslide Ltd. closes a strategic license agreement for the Asian market and round D investment round with a consortium of Chinese investors.
May 10, 2015
Polyheal Ltd. enters into a manufacturing and distribution license agreement with Praxis Pharmaceutical S.A.
May 3, 2015
Intec Pharma Ltd. enters into a Research, Option and Licensing Agreement with one of the world’s top 20 pharmaceutical companies, in terms of market cap.
April 26, 2015
